{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:50:47Z","timestamp":1792432247071,"version":"4.5.0"},"reference-count":57,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>A new series of trimethoprim (TMP) analogs containing amide bonds (1\u20136) have been synthesized. Molecular docking, as well as dihydrofolate reductase (DHFR) inhibition assay were used to confirm their affinity to bind dihydrofolate reductase enzyme. Data from the ethidium displacement test showed their DNA-binding capacity. Tests confirming the possibility of DNA binding in a minor groove as well as determination of the association constants were performed using calf thymus DNA, T4 coliphage DNA, poly (dA-dT)2 and poly (dG-dC)2. Additionally, the mechanism of action of the new compounds was studied. In conclusion, some of our new analogs inhibited DHFR activity more strongly than TMP did, which confirms, that the addition of amide bonds into the analogs of TMP increases their affinity towards DHFR.<\/jats:p>","DOI":"10.3390\/molecules25010116","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:42:47Z","timestamp":1577446967000},"page":"116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Trimethoprim: An Old Antibacterial Drug as a Template to Search for New Targets. Synthesis, Biological Activity and Molecular Modeling Study of Novel Trimethoprim Analogs"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-1547","authenticated-orcid":false,"given":"Agnieszka","family":"Wr\u00f3bel","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Bialystok, 15222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Maliszewski","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Bialystok, 15222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Baradyn","sequence":"additional","affiliation":[{"name":"Department of Physical Chemistry, University of Bialystok, Institute of Chemistry, 15245 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-0480","authenticated-orcid":false,"given":"Danuta","family":"Drozdowska","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Bialystok, 15222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bcp.2005.10.052","article-title":"Dihydrofolate reductase inhibitors as antibacterial agents","volume":"71","author":"Hawser","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/092986706775527938","article-title":"Towards species-specific antifolates","volume":"13","author":"Chan","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"ref_3","unstructured":"Champe, P.C., and Harvey, R.A. (1994). Lippincott\u2019s Illustrated Reviews: Biochemistry, Lippincott Williams and Wilkins. [2nd ed.]."},{"key":"ref_4","unstructured":"Foye, W.O., Lemke, T.L., and Williams, D.A. (2005). Principles of medicinal chemistry, Williams and Wilkins, Media. [4th ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2184.1997.tb00918.x","article-title":"Unbalanced growth in mouse cells with amplified dhfr genes","volume":"30","author":"Snapka","year":"1997","journal-title":"Cell Prolif."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejmech.2017.01.033","article-title":"Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential non-classical lipophilic antifolates targeting dihydrofolate reductase","volume":"128","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","first-page":"23","article-title":"Eukaryotic dihydrofolate reductase","volume":"70","author":"Blakley","year":"1995","journal-title":"Adv. Enzymol. Relat. Areas. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/prot.22383","article-title":"Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim","volume":"76","author":"Heaslet","year":"2009","journal-title":"Proteins"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15328","DOI":"10.1038\/srep15328","article-title":"The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling","volume":"5","author":"Hong","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_10","first-page":"247","article-title":"Dihydrofolate reductase as a versatile drug target in healthcare","volume":"7","author":"Rashid","year":"2016","journal-title":"JPP"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/febs.13662","article-title":"Structural analysis of dihydrofolate reductases enables rationalization of antifolate binding affinities and suggests repurposing possibilities","volume":"283","author":"Bhosle","year":"2016","journal-title":"FEBS J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/jm00105a008","article-title":"Optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase","volume":"34","author":"Selassie","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bmc.2014.11.009","article-title":"Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis","volume":"23","author":"Nammalwar","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/AAC.45.12.3293-3303.2001","article-title":"Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptosporidium parvum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity Correlations","volume":"45","author":"Nelson","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/febs.13244","article-title":"Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: Detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors","volume":"282","author":"Srinivasan","year":"2015","journal-title":"FEBS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/AAC.40.6.1371","article-title":"6,7-disubstituted 2,4-diaminopteridines: novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase","volume":"40","author":"Jackson","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejmech.2015.08.021","article-title":"Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase","volume":"103","author":"Srinivasan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Raimondi, M.V., Randazzo, O., La Franca, M., Barone, G., Vignoni, E., Rossi, D., and Collina, S. (2019). DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents. Molecules, 24.","DOI":"10.3390\/molecules24061140"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.2174\/0929867325666180209143715","article-title":"Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry","volume":"25","author":"Crowley","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_20","first-page":"1","article-title":"Recent Design and Structure-Activity Relationship Studies on Modifications of DHFR Inhibitors as Anticancer Agents","volume":"26","author":"Drozdowska","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/jm00106a001","article-title":"The renewed potential for folate antagonists in contemporary cancer chemotherapy","volume":"34","author":"Berman","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJM198803103181004","article-title":"Methotrexate in the treatment of corticosteroid-dependent asthma. A double blind crossover study","volume":"318","author":"Mullarkey","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/jm00177a025","article-title":"Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethyloxybenzyl)-5-methylpyrido[2,3-d]pyrimidine","volume":"23","author":"Grivsky","year":"1980","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1021\/jm960878u","article-title":"Folate based inhibitors of thymidylate synthase","volume":"40","author":"Bavetsias","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1021\/jm991119p","article-title":"Design and synthesis of cyclopenta[g]quinazoline-based antifolate as inhibitors of thymidylate synthase and potential antitumor agents","volume":"43","author":"Bavetsias","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/jm00394a038","article-title":"Antimalarial drugs. 63. Synthesis and antimalarial and antitumor effects of 2-amino-4-(hydrazino and hydroxyamino)-6-[(aryl)thio]quinazolines","volume":"30","author":"Werbel","year":"1987","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.bmcl.2005.01.083","article-title":"Synthesis and in vitro antitumor activity of 4(3H)-quinazolione derivatives with dithiocarbamate side chains","volume":"15","author":"Cao","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/jm020495y","article-title":"Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high- throughput synthesis and screening","volume":"46","author":"Wyss","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drup.2014.10.002","article-title":"The folate receptor as a rational therapeutic target for personalized cancer treatment","volume":"17","author":"Assaraf","year":"2014","journal-title":"Drug Resist. Updat."},{"key":"ref_30","unstructured":"Drugs.com (2019, November 21). Trimethoprim. Available online: https:\/\/www.drugs.com\/pro\/trimethoprim.html."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003495-198223060-00001","article-title":"Trimethoprim: A Review of itsantibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections","volume":"23","author":"Brogden","year":"1982","journal-title":"Drugs"},{"key":"ref_32","unstructured":"Sirotank, F.M., Burchall, J.J., and Ensminger, W.B. (1984). Folate Antagonists as Therapeutic Agents, Academic Press."},{"key":"ref_33","first-page":"5","article-title":"Trimethoprim and other non-classical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors","volume":"73","author":"Arciszewska","year":"2019","journal-title":"J. Antibiot."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fchem.2019.00475","article-title":"Multicomponent Reactions Upon the Known Drug Trimethoprim as a Source of Novel Antimicrobial Agents","volume":"7","author":"Pedrola","year":"2019","journal-title":"Front. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1021\/jm300644g","article-title":"Mechanism inspired the development of rationally designed dihydrofolate reductase inhibitors as anticancer agents","volume":"55","author":"Singh","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jmgm.2010.11.004","article-title":"2,4-Diamino-5-(2\u2032-aryl-propargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition","volume":"29","author":"Algul","year":"2011","journal-title":"J. Mol. Graph. Model."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes","volume":"14","author":"Barreiro","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed Multiple Ligands. An Emerging Drug Discovery Paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bmc.2005.09.011","article-title":"The benefits of the multi-target approach in drug design and discovery","volume":"14","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.2174\/092986711797535344","article-title":"Designed multiple ligands for cancer therapy","volume":"18","author":"Meegan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/ja01145a113","article-title":"Netropsin, a new antibiotic producedby a Streptomyces","volume":"73","author":"Finlay","year":"1951","journal-title":"JACS"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0005-2787(79)90496-9","article-title":"Netropsin, a DNA-binding oligopeptidestructural and binding studies","volume":"561","author":"Berman","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_43","first-page":"124","article-title":"Synthesis, DNA binding and antiviral activity of distamycin analogues containing different heterocyclic moieties","volume":"1","author":"Arcamone","year":"1986","journal-title":"Anti-Cancer Drug Des."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2174\/1568026615666150413155251","article-title":"Minor-Groove Binding Agents: Rational Design of Carboxamide Bond Isosteres","volume":"15","author":"Ong","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102923","DOI":"10.1016\/j.bioorg.2019.102923","article-title":"Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4(3H)-ones","volume":"88","author":"Sabry","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.3390\/molecules190811300","article-title":"Semi-Automatic Synthesis, Antiproliferative Activity and DNA-Binding Properties of New Netropsin and bis-Netropsin Analogues","volume":"19","author":"Szerszenowicz","year":"2014","journal-title":"Molecules"},{"key":"ref_47","first-page":"47","article-title":"Antiproliferative effects on breast cancer cells and some interactions of new distamycin analogues with dna, endonucleases and dna topoisomerases","volume":"73","author":"Drozdowska","year":"2016","journal-title":"Acta Pol. Pharm.-Drug Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/nar\/7.3.547","article-title":"Review: Ethidium fluorescence assays. Part 1. Physicochemical studies","volume":"7","author":"Morgan","year":"1979","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/jm00125a024","article-title":"Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin","volume":"32","author":"Debart","year":"1989","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/ar00084a001","article-title":"Newer approaches to the study of the mechanisms of action of antitumor antibiotics","volume":"15","author":"Lown","year":"1982","journal-title":"Acc. Chem. Res."},{"key":"ref_51","unstructured":"Sigma Aldrich (2019, November 21). Technical Bulletin. Available online: https:\/\/www.sigmaaldrich.com\/content\/dam\/sigmaaldrich\/docs\/Sigma\/Bulletin\/cs0340bul.pdf."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2018.05.059","article-title":"Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR)","volume":"155","author":"Francesconi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rana, R.M., Rampogu, S., Zeb, A., Son, M., Park, C., Lee, G., Yoon, S., Baek, A., Parameswaran, S., and Park, S.J. (2019). In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics. J. Clin. Med., 8.","DOI":"10.3390\/jcm8020233"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/molecules16043066","article-title":"New solid phase synthesis of distamycin analogues","volume":"16","author":"Drozdowska","year":"2011","journal-title":"Molecules"},{"key":"ref_55","first-page":"115","article-title":"Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition","volume":"64","author":"Drozdowska","year":"2007","journal-title":"Acta Pol. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1107\/S0907444904030422","article-title":"Understanding the Role of Leu22 Variants in Methotrexate Resistance: Comparison of Wild-type and Leu22Arg Variant Mouse and Human Dihydrofolate Reductase Ternary Crystal Complexes with Methotrexate and NADPH","volume":"61","author":"Cody","year":"2005","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/1\/116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:46:15Z","timestamp":1760190375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/1\/116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["molecules25010116"],"URL":"https:\/\/doi.org\/10.3390\/molecules25010116","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]}}}